Jed Shugerman, Professor at Fordham Law, talks Paul Manafort's lawsuit against Robert Mueller and deputy attorney general Rod Rosenstein, which alleges Mueller's authority in the Russia investigation is too broad.
Shugerman weighs in on whether Manafort actually has a case with his lawsuit. He notes that the case may be a way to undermine Mueller's authority and show the president loyalty in hopes of a potential pardon.
We dig deep into what lengths the president would have to go to in order to fire Mueller and the ramifications of the cease-and-desist letter that Trump has filed against Steve Bannon and author Michael Wolff.
Intel CEO Lip-Bu Tan says he’s “always operated within the highest legal and ethical standards” after coming under pressure following President Donald Trump’s call for him to resign.
Millions of Americans saving for retirement through 401(k) accounts could have the option of putting their money in higher-risk private equity and cryptocurrency investments.
A new federal rule would make it easier for companies to use drones over longer distances out of sight of the operator without having to go through a cumbersome waiver process.
President Donald Trump has signed the GENIUS Act into law, setting new regulations for stablecoins, a type of cryptocurrency tied to assets like the U.S. dollar.
A top Federal Reserve official said late Thursday that the central bank should cut its key interest rate later this month, carving out a different view than that of Chair Jerome Powell
Stocks fell on Wall Street as the Trump administration stepped up pressure on trading partners to make deals before punishing tariffs imposed by the U.S. take effect.
A stark disagreement over regulating AI in Republicans’ tax cut and spending bill is the latest tension among conservatives about whether to let states continue to put guardrails on emerging technologies or minimize such interference.
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
